KU-812E is a well-established human cell line derived from a patient with chronic myeloid leukemia (CML). Due to its well-documented genetic and phenotypic characteristics, this cell line has played an important role in advancing our understanding of leukemia biology, drug resistance, and treatment response. KU-812E cells are derived from the peripheral blood of CML patients in blast crisis and possess typical properties of hematopoietic progenitors, such as expression of erythroid markers and differentiation capacity. In addition, KU-812E cells are frequently used in studies focused on mechanisms of drug resistance, providing insights into the molecular pathways that leukemic cells exploit to evade chemotherapy. Researchers frequently use these cells to identify new drug targets and develop combination therapies aimed at overcoming drug resistance and achieving better clinical outcomes for CML patients.
GFP/Luc reporter cell lines, particularly the KU-812E variant, represent a major innovation in biomedical research, especially in studies involving gene expression, cell signaling, and cancer research. This reporter cell line is derived from the KU-812E human cell line, which was derived from a patient with chronic myeloid leukemia (CML) and has been genetically engineered to express green fluorescent protein (GFP) and luciferase (Luc) reporter genes. The GFP gene encodes a protein that fluoresces green under a specific wavelength of light, allowing for real-time, non-invasive visualization of cellular processes. This is particularly useful in live cell imaging, where researchers can track dynamic changes in gene expression, cellular localization, or protein-protein interactions without disturbing the cells. On the other hand, the luciferase reporter system provides a highly sensitive and quantitative measurement of gene expression. Luciferase catalyzes a luminescent reaction, and the intensity of the emitted light is directly related to the level of luciferase expression. This luminescence can be easily measured with a luminometer, providing a reliable method for high-throughput screening and real-time monitoring.
1. Drug Screening and Development: GFP reporter cell lines derived from OCI-AML-3 are often used in high-throughput drug screening assays to identify novel therapeutic agents. Green fluorescent protein (GFP) can be used as a marker, allowing researchers to monitor cell viability, proliferation, and response to various drug treatments in real time. This is particularly useful for developing targeted therapies for acute myeloid leukemia (AML).
2. Gene Expression Studies: The GFP Reporter Cell Line - OCI-AML-3 facilitate the study of gene expression and regulation. By integrating GFP into the genome, researchers can visualize and quantify the expression patterns of specific genes under various conditions. This is valuable for understanding the molecular mechanisms driving AML and identifying potential genetic targets for treatment.
3. In vitro Modeling of AML: GFP Reporter Cell Line - OCI-AML-3 facilitates the creation of in vitro models of AML. They provide a controlled environment to study the biology of leukemia, including cell signaling pathways, differentiation, and interactions with the bone marrow microenvironment. This helps to elucidate the pathogenesis of the disease and test the efficacy of new therapeutic compounds.
4. Cell Tracking and Migration Studies: GFP-labeled OCI-AML-3 cells can be used to study cell migration, invasion, and homing in preclinical models. GFP fluorescence allows easy tracking of leukemic cells, which is critical for understanding the mechanisms of metastasis and tissue invasion in AML. These insights can guide the development of therapeutics designed to prevent or limit the spread of the disease.
5. Functional Genomics and RNAi Screening: GFP reporter cell lines are valuable tools for functional genomics studies and RNA interference (RNAi) screening. Researchers can perform loss-of-function or gain-of-function studies to determine the role of specific genes in AML progression and maintenance. GFP is a convenient marker that can be used to evaluate the consequences of genetic manipulations and identify key molecular drivers of leukemia.
Customer Reviews
Robust and stable
GFP expression remained robust and stable over multiple passages, making it very easy to track the response of the cells over time. Highly recommended for any lab that needs a reliable fluorescent reporter!
High-quality service
In addition to the product itself, the customer service team was extremely helpful and responsive. They answered all of our questions promptly and provided excellent technical support to ensure that our experiments with the GFP reporter cell line - OCI-AML-3 ran smoothly.
Versatile research applications
This cell line has greatly facilitated our research on leukemia. GFP fluorescence allows for direct visualization and analysis of AML-3 cell behavior under a variety of conditions. It is a powerful tool for in vitro studies and potential in vivo applications.
United Kingdom
02/13/2024
Write a Review